Professor Alexander Yaw Debrah, a Ghanaian parasitologist, recently won the €50,000 EDCTP Dr. Pascoal Mocumbi Prize in 2025 for his contributions to global health research. His work has been significant in elephantiasis research, including identifying genetic links to conditions such as elephantiasis and hydrocele, and supporting the use of low-cost antibiotics like doxycycline for treatment.

However, the current medical consensus shows that elephantiasis (lymphatic filariasis) treatment involves management rather than a permanent cure. Current treatment regimens include mass drug administration of dual therapy consisting of diethylcarbamazine (DEC) and albendazole (ALB), with newer treatments being piloted.

Prof. Debrah’s work represents important advances in understanding and treating the disease, and his recent inaugural lecture was titled “Eliminating Filariasis: A New Hope for an Old Battle”, but this appears to focus on elimination strategies rather than claiming a permanent cure has been found.

The lack of widespread coverage might be because the research represents significant progress in treatment and elimination efforts rather than a complete cure breakthrough. Would you like me to search for more specific information about any particular aspect of this research?